Clinical trialNCT04939610RecruitingPhase 1/PHASE2Interventional

A Study of 177Lu-FAP-2286 in Advanced Solid Tumors

SponsorNovartis PharmaceuticalsEnrollment222Solid Tumor

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Novartis Pharmaceuticals
Novartis Pharmaceuticals
Study Director
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

40 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Australia

Novartis Investigative Site
Adelaide, South Australia, Australia
Recruiting
Novartis Investigative Site
Melbourne, Victoria, Australia
Recruiting
Novartis Investigative Site
Melbourne, Victoria, Australia
Dr. Brenda Lee, MD
Recruiting
Novartis Investigator Site
Murdoch, Western Australia, Australia
Zeyad Al-Ogaili
Recruiting

Canada

Novartis Investigating Site
London, Ontario, Canada
Recruiting
London Health Sciences Centre
Toronto, Ontario, Canada
Recruiting
Novartis Investigative Site
Montreal, Quebec, Canada
Recruiting

France

Novartis Investigator Site
Montpellier, Cedex 5, France
Recruiting
Novartis Investigator Site
Bordeaux, France
Recruiting
Novartis Investigator Site
Clermont-Ferrand, France
Recruiting
Novartis Investigating Site
Marseille, France
Recruiting
Novartis Investigator Site
Vandœuvre-lès-Nancy, France
Recruiting

Italy

Novartis Investigative Site
Meldola, Emilia-Romagna, Italy
Recruiting
Novartis Investigating Site
Milan, Italy
Recruiting
Novartis Investigator Site
Naples, Italy
Giuseppe Curigliano
Recruiting

Spain

Novartis Investigative Site
A Coruña, Spain
Manuel Fernandez Bruno
Recruiting
Novartis Investigating Site
Badalona, Spain
Recruiting
Novartis Investigating Site
Madrid, Spain
Recruiting
Novartis Investigating Site
Madrid, Spain
Recruiting
Novartis Investigating Site
Madrid, Spain
Recruiting

United States

Uab Comprehensive Cancer Center
Birmingham, Alabama, United States
Jonathan McConathy, MD
Recruiting
City of Hope
Duarte, California, United States
Hannah Chang
Recruiting
Hoag Hospital Irvine
Irvine, California, United States
Gary Ulaner
Recruiting
University of California Los Angeles (ucla)
Los Angeles, California, United States
Dr. Zev Wainberg, MD
Recruiting
Ucsf Medical Center
San Francisco, California, United States
Andrew Ko
Recruiting
Mayo Clinic
Jacksonville, Florida, United States
Recruiting
University of Miami Hospital and Clinics
Miami, Florida, United States
Dr. Aman Chauhan
Recruiting
University of Chicago Medical Center
Chicago, Illinois, United States
Recruiting
University of Iowa Hospitals and Clinics
Iowa City, Iowa, United States
Yusuf Menda
Recruiting
Karmanos Cancer Institute
Detroit, Michigan, United States
Recruiting
Mayo Clinic
Rochester, Minnesota, United States
Recruiting
Saint Louis University Hospital
St Louis, Missouri, United States
Recruiting
Columbia University Medical Center
New York, New York, United States
Ryan Moy
Recruiting
Memorial Sloan Kettering Cancer Center
New York, New York, United States
Recruiting
Unc Hospitals
Chapel Hill, North Carolina, United States
Recruiting
Oregon Health and Science University
Portland, Oregon, United States
Recruiting
Upmc Hillman Cancer Center
Pittsburgh, Pennsylvania, United States
Recruiting
University of Texas Md Anderson Cancer Center
Houston, Texas, United States
Recruiting
Univ of Utah, Huntsman Cancer Institute
Salt Lake City, Utah, United States
Recruiting
Fred Hutchinson Cancer Center
Seattle, Washington, United States
Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 30 Jul 2021
Primary completion: 30 Jun 2026
Completion: 30 Jun 2028
Last update posted: 23 Apr 2026
Registered enrollment: 222
Registry id: NCT04939610

Cross-registrations

EU-CTR / CTIS (EudraCT)2023-508995-12-00

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.